Ryan MacDonald
Stock Analyst at Needham
(3.09)
# 1,135
Out of 4,767 analysts
317
Total ratings
39.11%
Success rate
0.76%
Average return
Main Sectors:
Stocks Rated by Ryan MacDonald
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Reiterates: Buy | $29 | $25.45 | +13.95% | 19 | Mar 13, 2025 | |
| UDMY Udemy | Reiterates: Buy | $11 | $7.91 | +39.06% | 14 | Mar 12, 2025 | |
| LPSN LivePerson | Reiterates: Hold | n/a | $0.92 | - | 10 | Mar 6, 2025 | |
| YEXT Yext, Inc. | Reiterates: Buy | $10 | $6.02 | +66.11% | 12 | Mar 6, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $270 | $227.80 | +18.53% | 21 | Mar 6, 2025 | |
| DCGO DocGo | Maintains: Buy | $7 → $4 | $2.87 | +39.37% | 14 | Feb 28, 2025 | |
| DUOL Duolingo | Maintains: Buy | $385 → $400 | $272.49 | +46.79% | 13 | Feb 28, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $25 → $30 | $23.38 | +28.31% | 2 | Feb 28, 2025 | |
| TDOC Teladoc Health | Reiterates: Hold | n/a | $8.49 | - | 10 | Feb 27, 2025 | |
| ZETA Zeta Global Holdings | Reiterates: Buy | $43 | $13.70 | +213.87% | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.00 | - | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $70 | $42.17 | +66.01% | 4 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.78 | - | 17 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $61 | $31.54 | +93.41% | 3 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $9.54 | +57.23% | 3 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.76 | - | 4 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.89 | - | 7 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.78 | +62.24% | 16 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.59 | - | 13 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.98 | - | 17 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $84 | $57.96 | +44.93% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $60 | $28.91 | +107.54% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $1.48 | +35.14% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $8.73 | - | 11 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $255 | $235.65 | +8.21% | 4 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $20.84 | +91.94% | 15 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $92 | $119.51 | -23.02% | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $15 | $23.15 | -35.21% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $500 | $598.32 | -16.43% | 12 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $640 → $450 | $202.82 | +121.87% | 13 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $12 | $4.73 | +153.70% | 6 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $9.16 | +20.09% | 3 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $63.30 | - | 1 | Oct 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $115 → $145 | $377.84 | -61.62% | 2 | Mar 17, 2017 |
Phreesia
Mar 13, 2025
Reiterates: Buy
Price Target: $29
Current: $25.45
Upside: +13.95%
Udemy
Mar 12, 2025
Reiterates: Buy
Price Target: $11
Current: $7.91
Upside: +39.06%
LivePerson
Mar 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.92
Upside: -
Yext, Inc.
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $6.02
Upside: +66.11%
Veeva Systems
Mar 6, 2025
Reiterates: Buy
Price Target: $270
Current: $227.80
Upside: +18.53%
DocGo
Feb 28, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $2.87
Upside: +39.37%
Duolingo
Feb 28, 2025
Maintains: Buy
Price Target: $385 → $400
Current: $272.49
Upside: +46.79%
Privia Health Group
Feb 28, 2025
Maintains: Buy
Price Target: $25 → $30
Current: $23.38
Upside: +28.31%
Teladoc Health
Feb 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.49
Upside: -
Zeta Global Holdings
Feb 26, 2025
Reiterates: Buy
Price Target: $43
Current: $13.70
Upside: +213.87%
Feb 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.00
Upside: -
Feb 25, 2025
Maintains: Buy
Price Target: $56 → $70
Current: $42.17
Upside: +66.01%
Feb 25, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.78
Upside: -
Feb 25, 2025
Maintains: Buy
Price Target: $31 → $61
Current: $31.54
Upside: +93.41%
Feb 21, 2025
Reiterates: Buy
Price Target: $15
Current: $9.54
Upside: +57.23%
Feb 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $2.76
Upside: -
Feb 13, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.89
Upside: -
Jan 31, 2025
Reiterates: Buy
Price Target: $11
Current: $6.78
Upside: +62.24%
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $2.59
Upside: -
Jan 8, 2025
Downgrades: Hold
Price Target: n/a
Current: $6.98
Upside: -
Dec 13, 2024
Maintains: Buy
Price Target: $89 → $84
Current: $57.96
Upside: +44.93%
Nov 8, 2024
Maintains: Buy
Price Target: $50 → $60
Current: $28.91
Upside: +107.54%
Nov 8, 2024
Reiterates: Buy
Price Target: $2
Current: $1.48
Upside: +35.14%
May 24, 2024
Reiterates: Hold
Price Target: n/a
Current: $8.73
Upside: -
Apr 26, 2024
Maintains: Buy
Price Target: $270 → $255
Current: $235.65
Upside: +8.21%
Dec 14, 2023
Reiterates: Buy
Price Target: $40
Current: $20.84
Upside: +91.94%
Jun 20, 2023
Maintains: Buy
Price Target: $84 → $92
Current: $119.51
Upside: -23.02%
Feb 27, 2023
Maintains: Hold
Price Target: $12 → $15
Current: $23.15
Upside: -35.21%
May 6, 2022
Maintains: Buy
Price Target: $700 → $500
Current: $598.32
Upside: -16.43%
Feb 9, 2022
Maintains: Buy
Price Target: $640 → $450
Current: $202.82
Upside: +121.87%
May 12, 2021
Maintains: Buy
Price Target: $15 → $12
Current: $4.73
Upside: +153.70%
Mar 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $9.16
Upside: +20.09%
Oct 31, 2017
Initiates: Neutral
Price Target: n/a
Current: $63.30
Upside: -
Mar 17, 2017
Upgrades: Buy
Price Target: $115 → $145
Current: $377.84
Upside: -61.62%